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Sepsis is highly correlated with mortality and morbidity. Sepsis is a clinical 
condition demarcated as the existence of infection and systemic inflammatory 
response syndrome, SIRS. Confirmation of infection requires a blood culture test, 
which requires incubation, and thus results take at least 48 hours for a syndrome 
that requires early direct treatment. Since sepsis has a strong inflammatory 
component, it is hypothesized that metabolic markers affected by inflammation, 
such as insulin sensitivity, might provide a metric for more rapid, real-time 
diagnosis. This study uses clinical data from 30 sepsis patients (7624 hours in 
ICU) of whom 60% are male. Median age and median Apache II score are 63 
years and 19, respectively. Model-identified insulin sensitivity (SI) profiles were 
obtained for each patient, and insulin sensitivity and its hourly changes were 
correlated with modified hourly sepsis scores (SSH1). SI profiles and values were 
similar across the cohort. The sepsis score is highly variable and changes rapidly. 
The modified hourly sepsis score, SSH1, shows a better relation with insulin 
sensitivity due to less fluctuation in the SIRS element. Median SI and ΔSI of the 
cohort is 4.193e-4 and 4.253e-6 L/mU.min, respectively. P-values are 0.0392 
(SSH1 = 0, SSH1 = 2), 0.3337 (SSH1 = 0, SSH1 = 3), and 0.0581 (SSH1 = 1, SSH1 = 2), 
respectively. CDF of SI indicates that insulin sensitivity is more significant when 
comparing hourly sepsis score at a very distinguish level.  
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Sepsis is an increasingly common condition and a leading source of mortality and 
morbidity in Intensive Care Unit (ICU). The mortality rates of more than 50% 
have not improved in the past 30 years, despite intense research advances in 
treatment. Additionally, sepsis is common cause of death particularly in non-
coronary ICU [1] and highly associated with mortality in critically ill patients [2-
4]. 
 
Infection and systemic inflammatory responses (SIRS) are the main elements of 
sepsis. Infection is produced by the invasion of tissue or fluid by pathogenic 
microorganisms [5]. In contrast, SIRS is related with a response of the immune 
system to infection, which is highly related to organ dysfunction and organ 
failure [5,6], which also occur frequently with and without sepsis. However,  in 
many cases, infection is suspected without being able to be microbiologically 
confirmed for several reasons, creating so-called "culture negative" sepsis [7] 
and further complicating diagnosis.  
 
Sepsis has been classified into several stages, including sepsis, severe sepsis, 
septic shock, and refractory septic shock. Despite the definition of sepsis and its 
classification, these terms do not precisely characterize the patient’s stage and 
condition, and may be confounded by other issues. More specifically, sepsis, at all 
levels, is a syndrome or collection of conditions. Grouped together as "sepsis" 
they categorize patients with a significantly increased risk of death. Hence, 
unfortunately perhaps, sepsis is as much of a patient category as it is a specific 
physiological condition. This issue makes sepsis diagnosis quite difficult. 
 
According to Rivers and colleagues [8], early goal-directed treatment (EGDT) 
provide better outcome by reducing mortality from 46.5% to 30.5% of sepsis 
cases. Clinical studies on septic shock by Rivers et al. [8] observed lower 
mortality rates in patients assigned to EGDT (42.3%) compared to standard 
therapy (56.8%). Even if they survive, sepsis usually reduces quality life [9-12], 
especially if not specifically treated. However, some studies [13-15] unable to 
repeat the results of Rivers et al. [8], indicating that early treatment is highly 
subject to patient conditions but still necessary in sepsis. 
 
Nevertheless, diagnosing sepsis in critical care has many challenges. The long 
process of obtaining blood culture results can delay care and the resulting lack of 
knowledge makes optimizing antibiotic or other treatments difficult. However, 
blood culture results are still the most accepted gold standard to clinically 
diagnose infection. Therefore, the inability to guarantee accurate, early diagnosis 
affects treatment selection, patient condition, and thus outcomes. What needed is 
a rapid test or a readily available parameter that can provide insight for 
clinicians to determine appropriate treatment and medications.  
 
Several studies have shown that model-based SI (insulin sensitivity) can be used 
as an indicator for severity of illness, as this metabolic marker is reflective of the 
inflammatory state in these patients. In particular, Blakemore et al. [16] have 
shown that insulin sensitivity of a patient decreased as the patient condition 
worsens. Moreover, it has been previously documented that SI decreases with 
worsening condition and increases with improvement in patient condition [17-
20], even though its more common use is in model-based treatment of 
hyperglycemia [20]. This important information can be used to correlate 
between a patient condition and other complications, which are highly 
associated with hyperglycemia. 
  
In this study, the relationship between model-based insulin sensitivity and a 
clinically accepted parameter, sepsis score is investigated. More specifically, a 
clinically validated model-based SI [21-25] and its hourly evolution have been 
compared and examined to determine the relationship between sepsis score and 
another modified sepsis score that can be used for hourly intervention. If there is 
a clear relation between insulin sensitivity and sepsis score, SI can therefore 
become a marker to evaluate sepsis progression in real-time.    
 
  
Materials and Methods 
i. Glucose-Insulin System Model 
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The system model used in this analysis is listed in Equations (1) to (3), where G 
is the total plasma glucose, Q is the effect of infused insulin, and I represent 
plasma insulin. The term pG and aG captures patient endogenous glucose removal 
and insulin-mediated glucose removal saturation parameter, respectively. P 
represents the glucose appearance rate in plasma from carbohydrate content. 
EGPmax represents the production of maximum endogenous glucose while CNS 
represents central nervous system (CNS) glucose uptake. 
 
Insulin sensitivity, SI represents patient-specific insulin-mediated glucose 
removal, which also indicates evolving patient condition [19,26,27]. Endogenous 
insulin secretions are IB and kI while intravenous insulin administration is uex 
[28].  Transport rates and saturation constants are n, k, aG, aI, and volumes are VG, 
and VI that have been validated through several studies [29,30]. 
 
Using the glucose-insulin system model, patient-specific glycemic response can 
be generated for time-varying SI, and hour-to-hour variation as patient condition 
evolves. The patient-specific profile can be obtained by fitting the model to 
retrospective clinical data for blood glucose measurements, insulin and 
carbohydrate administration input data from the protocols. The resulting insulin 
sensitivity profile has been validated in correlation to gold standard euglycemic 
clamp and intravenous glucose tolerance test data [25,31], as well as in silico 
virtual trials [27,29,32,33]. 
 
ii. Sepsis Score 
In this study, a well-known sepsis score is calculated following the criteria 
prepared by the American College of Chest Physicians - Society of Critical Care 
Medicine (ACCP-SCCM) [5]. This sepsis score was initially created in 2001 during 
the International Sepsis Definitions Conference. In general, this sepsis score is 
calculated based on two commonly used criteria, which are SIRS and Sepsis-
related Organ Failure (SOFA) [6].  
 
Table 1 shows the sepsis score criteria. Details of the criteria for determining the 
SIRS and organ failure (OF) scores can be found in Suhaimi et al [28]. Like other 
scores, this scoring is widely used to represent the complexity level of the 
syndrome consistently, for evaluation and standardized description. The 
advantages include a consistent means of allowing clinicians to assess patient 
condition to guide care [28]. It is normally calculated daily, and uses a hierarchy 
of criteria defined in Table 1 based on an average of 24 hours of treatment and 
response to care. 
 
 
Table 1.  Sepsis score criteria 
 
 







Normal 0       













✓ ✓ ✓ ✓ ✓ ✓ 
 
  
iii. Hourly Scoring Systems (SSh and SSH1) 
To obtain a useful score that can be used by a clinician to guide diagnosis and 
treatment in clinical real-time, defined here as hourly or more frequent for 
sepsis, the current sepsis score needs to be modified. Figure 1 shows the 
classification for calculating SSh, as an hourly scoring system that represent 
sepsis condition. SSh is determined by calculating the summation of individual 
component scores used to calculate the current sepsis score. In contrast, the 
original sepsis score is determined by following the hierarchy in Table 1. 
 
In Figure 1, each element of A to D has a value of 1 if they are true. For example, 
at time t, if a patient had SIRS ≥ 2 and had an infection, the score for A will 
become 1. If the patient had SIRS ≥ 2 but was free from infection, the score for A 
is 0. Next, if the patient had mild or more severe organ dysfunction or failure, 
defined by SOFA ≥ 1 for at least one SOFA score component, at time t, B become 
1. Otherwise, it is 0. The same method is applied to the criteria C, and D, for fluid 
resuscitation and inotrope usage, respectively. Finally, the SSh value is calculated 
by summing the values of A, B, C and D, as presented in Equation 4. Therefore, 
the range of SSh is 0 to a maximum value of 4. 
 
Importantly, there is no hierarchy involved, which means that if a patient has all 
the criteria B, C and D, but no SIRS ≥ 2 due to treatment, then they still have a 
positive score for sepsis. This case would not hold in the original hierarchical 
definition in Table 1. The difference is that calculated daily, one needs only to 
have these criteria met daily and the hierarchy is useful. However, hourly 






Figure 1.  Components for determining an hourly sepsis score, SSh 
 
Finally, a further modified sepsis score SSH1 is introduced. This score is 
calculated like SSh in Figure 1. However, it eliminates part of criteria A regarding 
SSh = A+B+C+D
SIRS score, since almost all ICU patients meet this condition for many hours of 
their stay. Hence, it may not add resolution to include this score. 
 
iv. Sepsis Score Analyses  
Overall, there are thus two modified sepsis scores to consider, SSh and SSH1. 
These are compared to each other, the original unmodified sepsis score, and to 
insulin sensitivity profiles, level and hourly change in insulin sensitivity. The goal 
is to determine whether model-based insulin sensitivity profiles can stipulate a 
valuable additional biomarker or metric to help identify and diagnose sepsis, and 
at what level of sepsis this outcome might be possible. 
 
v. Patient Data and Retrospective Cohort 
A collection of clinical data was obtained from the ICU of Christchurch Hospital, 
New Zealand. There were a total of 30 patients that had sepsis during their stay 
and were selected in this study. They were identified by having positive blood 
culture results and also by a judgment of experienced senior intensive care 
clinicians.  The SIRS score was calculated for every hour for all of the patients.  In 
addition, all other data was collected for each patient and the metabolic 
treatment data, including insulin and nutrition given and resulting blood glucose 
measurements, as well as their timing, were collected and used to identify hourly 
patient specific SI profile for each patient. Approval by the Upper South Regional 
Ethics Committee of New Zealand has been obtained for this study and use of the 
data. The retrospective cohort information including the mortality status is 
shown in Table 2. 
 
Table 2.  Retrospective cohort information 
No Medical Subgroup Age Apache II 
score 
Sex Mortality 
1 Pneumonia 71 25 M  
2 Pneumonia 30 10 F  
3 ARDS 63 11 M  
4 Respiratory failure 76 17 M Y 
5 Type 1 DM 46 29 M Y 
6 Type 2 DM 78 19 F  
7 COPD 54 17 M  
8 CAP 88 24 M Y 
9 Sepsis 64 19 F  
10 Gastrectomy 49 12 M  
11 Pneumonia 56 18 M  
12 Sepsis 67 16 F  
13 COPD 55 13 M  
14 Pneumonia 78 15 M  
15 Sepsis 59 29 M  
16 Septic shock 49 19 F  
17 Septic shock 55 17 F  
18 Pneumonia 60 18 F  
19 Otitis 43 18 F  
20 Pneumonia 64 15 M Y 
21 CAP 61 17 F  
22 CAP 74 22 M  
23 Multiple trauma 63 19 F  
24 CAP 52 23 F  
25 Pneumonia 64 20 M Y 
26 CAP 75 23 M  
27 Pneumonia 75 21 M  
28 Pneumonia 70 27 F  
29 GBS 43 8 M  
30 CAP 80 24 M  
 
a. ARDS - Acute Respiratory Distress Syndrome  
b. COPD - Chronic Obstructive Pulmonary Disease 
c. CAP - Community Acquired Pneumonia 
d. GBS - Guillain-Barré Syndrome 
 
 
Table 3 summarizes the demographic and baseline criteria of the sepsis cohort, 
where male and female patients are 18 and 12, respectively. The median age of 
the cohort is 63 years whereas median [IQR] Apache II score is 19 [16-23]. Total 
hours in ICU for the sepsis cohort is 7624 hours, and median length of stay (LOS) 
is 10.5 days. 
 
Table 3.  Demographic and baseline criteria of the sepsis cohort. Median [IQR] is 




 Number of patients 30 
 Percentage of male 60% 
 Age 63 [54 – 74] 
 Apache II score 19 [16 – 23] 
 Total hours in ICU 7624 




 Temperature (°C) 36.6 [36.0 – 37.6] 
 Heart rate (beats/min) 97 [87 – 110] 
 Mean arterial pressure (mmHg) 73 [67 – 83] 
 White cell count (per Liter) 11.6 [7.9 – 20.4] 
 Partial pressure of carbon dioxide (mmHg) 47.5 [39.0 – 58.0] 




Results and Discussion 
i. Insulin sensitivity profile of the sepsis cohort 
Identified insulin sensitivity profiles, SI (t), for all 30 patients provide an hour-to-
hour trajectory for each patient, before, during and after sepsis.  Figure 2 
illustrates the per-patient cumulative distribution functions (CDFs) of SI for all 
30 patients, where the shaded area indicates the 5th to 95th percentile patients 
and the dotted line represents the median patient, with the 25th and 75th 
percentile patients also shown. It is clear that there is significant inter-patient 
and intra-patient variability in SI. Figure 2 also presents similar data in a box plot 
for each patient.   
 
Table 4 presents the SI results, hourly change in insulin sensitivity (ΔSI) and 
percentage of changes in insulin sensitivity (%ΔSI) across patients and cohort. 
Maximum SI values are highly variable across patients. The highest SI value in the 
cohort is 9.2734e-3 L/mU.min, in Patient 24. Median SI and median ΔSI of the 
cohort is 0.4193e-3 and 0.004253e-3 L/mU.min, respectively, where the latter 
value very near to 0 indicates that the median hour-to-hour change is no change 
in insulin sensitivity, matching prior reports [27]. This value also indicates that a 
sepsis patient, or post-sepsis patient, is equally likely to have a rise or fall in 
insulin sensitivity hour-to-hour, with no bias in direction of the change, although 
there is significant inter-patient variability seen in Table 3 when examining 






Figure 2.  Top: Per-patient insulin sensitivity CDFs for all 30 patients, shown as 
median, IQR and 5th – 95th percentile patients. Bottom: the same data shown 




Table 4.  Median insulin sensitivity, minimum and maximum insulin sensitivity, 
and median changes in insulin sensitivity among 30 patients in the sepsis cohort 








Median ΔSI  
(%) 
1 4.527 0.001 32.155 3.711 1.084 
2 4.433 1.540 6.897 -7.010 -1.261 
3 12.827 0.625 31.657 4.068 0.471 
4 1.657 0.001 4.870 5.307 3.349 
5 4.702 0.325 7.906 -1.072 -1.021 
6 4.927 1.900 19.234 2.825 0.562 
7 8.011 1.410 24.177 -1.676 -0.255 
8 3.674 0.114 16.201 6.680 1.531 
9 3.439 0.001 23.290 4.637 1.255 
10 4.026 0.001 19.655 5.655 1.597 
11 5.017 1.282 58.959 7.949 1.819 
12 3.223 0.001 17.804 7.216 1.967 
13 8.588 1.917 42.527 0.072 0.012 
14 4.379 1.062 35.339 -0.020 -0.004 
15 4.077 0.846 13.840 9.327 2.705 
16 4.176 1.623 25.738 1.969 0.573 
17 3.119 0.670 9.691 7.596 3.226 
18 4.101 1.589 66.076 0.097 0.003 
19 1.786 0.001 4.169 2.862 1.118 
20 1.171 0.001 5.768 6.515 4.243 
21 3.337 0.001 9.867 20.923 4.554 
22 3.400 1.089 10.220 8.619 2.053 
23 9.070 0.230 32.530 48.204 5.682 
24 3.920 0.001 92.734 17.926 7.999 
25 4.119 1.182 15.956 3.845 0.972 
26 5.093 0.830 25.005 2.852 0.883 
27 3.173 2.241 5.589 -20.532 -6.079 
28 4.103 0.263 74.211 7.589 0.845 
29 3.667 0.217 23.730 2.151 0.460 
30 2.653 0.001 21.980 3.381 1.132 
Cohort 4.193 0.001 92.734 4.253 1.114 
 
 
Figure 3 shows the 5th - 95th percentile, IQR (75% and 25%) and median (50%) 
for the hour-to-hour stochastic model created from the 30 patients based on the 
models developed by Lin et al. [27,34]. The variation distributions are plotted as 
SI (n+1) against SIn on the y-axis and the x-axis, respectively. The distribution 
indicates the hour-to-hour patient metabolic variability in SI. 
 
Figure 3.  Hourly insulin sensitivity distribution of the sepsis cohort 
 
ii. Unmodified sepsis score analysis 
Figure 4 shows the hourly distribution of sepsis score for the whole length of 
stay for two patients randomly selected from the sepsis cohort. In Figure 4, the 
score of Patient 22 changes effectively instantly, with a difference of two levels of 
sepsis score, as seen at minutes 1620 to 2160. Additionally, it can be observed 
that the sepsis score is highly variable between a score of 0 and 1 for most of the 
stay of Patient 24. These plots suggest that sepsis scores calculated daily do not 
capture the true state of sepsis, SIRS and infection in hourly measurement, which 
cannot change to two or even three stages at this fast. Instead, it shows how the 
hierarchical, unmodified sepsis score cannot be used hourly without the 
proposed modifications in Figure 1. 
Figure 4.  Hourly plot of the unmodified sepsis score for Patients 22 (top) 
and 24 (bottom) 
 
iii. Hourly sepsis score (SSh) of the sepsis cohort 
Figure 5 illustrates SSh for all 30 patients during their whole stay in ICU. Overall, 
there were a total of 7624 hours of treatment where patients had SSh = 2 for the 
most hours (43%). There were 25.9%, 9.8% and 2.6% of hours where patients 
had SSh scores of 1, 3 and 4, respectively. The remaining 18.7% of the total hours 
are where patients had SSh = 0. 
 
  Figure 5.  Cumulative hours of SSh for 30 patients in the sepsis cohort 
during their stay in ICU 
 
 
Figure 6 shows the hourly distribution of the modified sepsis score, SSh, and 
insulin sensitivity for the entire stay of the Patient 3 and Patient 24. The right 
panel of y-axes represents SSh and left panel of y-axes represents the insulin 
sensitivity value. Patient 3 had a higher score with a fluctuating score during the 
second half of the stay as compared to the original, unmodified sepsis score in 
Figure 4. In Figure 6, the SSh of Patient 24 is also highly variable, unlike the plot 








Figure 7 represents the cumulative data points of A, B, C and D when SSh = 1. 
There was 1976 measurement of SSh = 1 during the stay for all 30 patients in the 
cohort. A has the highest frequency followed by B, D and C. In Figure 7, criteria A 
dominates the total measurement of SSh at score 1 with a 56% (1086) of total 
measurements, reflecting the influence of SIRS score and how it is endemic to 
almost all ICU patients even without sepsis. Criteria B recorded the second 
greatest with a total of 690 measurements, followed by D and C with 104 and 96, 
respectively.  
 
Figure 7.  Comparison of score A, B, C and D components for SSh 
 
iv. Modified hourly sepsis score (SSH1) 
SSh in Figure 6 can still be unstable for the hourly assessment of sepsis condition 
due to high fluctuation seen in the per-patient plots, due primarily to the 
influence of SIRS score, which adds extra effective noise. SSH1 provides a more 
comprehensive and stable score with maximum and minimum values of 3 and 0, 
respectively. Figure 8 shows the hourly distribution of insulin sensitivity, SI, 
changes in insulin sensitivity (ΔSI), percentage of changes in insulin sensitivity 
(%ΔSI) and SSh1 for Patient 3 and Patient 24.  
 
       
 
Figure 8.  Hourly plot of SI, ΔSI, %ΔSI and SSH1 for Patient 3 (top) and Patient 
24 (bottom) 
 
It is clear in Figure 8 that there is a stronger correlation between insulin 
sensitivity and the modified hour sepsis score, SSH1. In general as sepsis declines 
patient-specific insulin sensitivity tends to rise and become more variable as 
condition improves. Thus, rising insulin sensitivity and increasing variability 
(SI) would be hypothesized to be markers of improving condition from sepsis, 
and vice versa for its diagnosis. 
 
Figure 9 presents the receiver operating characteristic (ROC) plot. X-axis in 
Figure 9 represents (1-specificity) while y-axis represents sensitivity. Plotted 
lines lay in a sequence according to the SSH1 value. As expected, higher SSH1 
values (SSH1 ≥ 3), for greater levels of sepsis, yield the best possible prediction 
using insulin sensitivity level alone, and the plots show a similar trend for all 
categories of SSH1. There is a small gap between SSH1 ≥ 1 and SSH1 ≥ 2, and a large 
gap has been observed between SSH1 ≥ 3 to the rest indicating it is more 
diagnostic for severe sepsis.  
 
Figure 9.  Receiver operating characteristic (ROC) plot showing the 
sensitivity and specificity relation of SSH1 and insulin sensitivity 
 
 
Figure 10 shows the CDFs of SI on the SSH1 score basis. SSH1 = 0 has the highest SI 
distribution followed by patients with SSH1 = 1, SSH1 = 2 and SSH1 = 3. However, 
the SI distribution for SSH1 = 0, 1 and 2 are almost overlaid. SI reduces as the 
patient condition worsens, as hypothesized. However, the discrimination, while 
significant (p<0.05), is not large and there is significant overlap that affects 
diagnostic value as seen in Figure 9 for these two levels. The p-values computed 
using Mann-Whitney test are shown in Figure 10. P-values are 0.6742 (SSH1 = 0, 
SSH1 = 1), 0.0392 (SSH1 = 0, SSH1 = 2), 0.3337 (SSH1 = 0, SSH1 = 3), 0.0581 (SSH1 = 1, 
SSH1 = 2), 0.4059 (SSH1 = 1, SSH1 = 3), and 0.8379 (SSH1 = 2, SSH1 = 3), respectively. 
The clearer difference when SSH1 = 3, the most severe septic state, shows more 
diagnostic potential and also reflects the ROC curve in Figure 9. 
  
 
Figure 10.  Cumulative distribution functions of insulin sensitivity grouped 
by SSh1.  
 
 
Insulin sensitivity profile provides important information on the metabolic 
status of any particular patient. In this study, insulin sensitivity distributions are 
very similar among the sepsis patients in the cohort as seen in Figure 3. Most of 
the patients in the cohort had a similar SI distribution.  
 
The dynamic change in SI from hour-to-hour also provides information on 
metabolic dynamics and insulin resistance in this cohort. Importantly, the 
variability of SI over the next hour is highly relying on its current value. 
Therefore, the stochastic model in Figure 3 represents the SI transition from one 
hour to the next and changes in variability may be indicative of changes in 
patient condition, creating a further potential biomarker. Moreover, SI and 
change in SI offer a further diagnostic value particularly at certain thresholds.    
 
Overall, from the whole length of stay for this sepsis cohort, the standard sepsis 
scores are fluctuating. Generally, the sepsis and infection condition of a patient 
would not change this fast. By definition, sepsis exists by the presence of SIRS 
and infection. However, the frequent change in Figure 4 suggests a failure of the 
score hierarchy typically used on a daily basis that takes the average or worst 
case of over the day.  This result may not be surprising since SIRS symptoms are 
treated, such as high temperature, thus negating the entire hierarchy if the SIRS 
criteria is not met. Hence, the SIRS score was used and excluded in the modified 
SSh and SSH1 scores, respectively analyzed here, which are calculated hourly and 
thus do not use the hierarchical scoring method used daily.  
 
From the plots in Figure 6, it can be concluded that SSh makes an improvement 
but not all non-physiological fluctuation is eliminated. Since SSh is calculated 
based on each component in determining the original sepsis score without a 
hierarchy, the score can be due to any set of criteria. It is thus more 
representative of true condition, but biased by the fluctuations in SIRS scores, 
which are endemic to all ICU patients and not just in sepsis. In particular, the 
high frequency of criteria A in Figure 7 showed that SIRS is a leading 
contributing factor in developing the SSh score, with more than 50% of the total 
score. These results thus justified the choice to also consider a sepsis score 
without SIRS criteria, SSh1, for analysis versus insulin sensitivity and its hour-to-
hour evolution. 
 
Overall, Figure 8 implies that SSH1 decreases with increases in insulin sensitivity, 
given that SI is above a certain threshold. However, patients might have different 
patient-specific thresholds or baseline values to indicate changes in their 
metabolic condition. Similarly, changes in SI may also vary between patients. 
Some patients may have a huge change in SI when shifting metabolic condition, 
while others may experience much smaller changes for the same event.  
 
Nevertheless, ΔSI and % ΔSI do not show a significant correlation to the SSH1 and 
thus may not add much as a biomarker. Equally, these results show that SI is an 
effective marker, but that patient-specific thresholds would be needed to make 
automated diagnosis possible without additional, external data. In particular, the 
relation of insulin sensitivity, SI to SSH1 may suggest SI as a significant marker in 
determining severe sepsis levels in critical illness.  
 
Hence, the ability to delivery very early diagnosis is unclear, but the negative 
predictive value of this marker alone is significant. Positive prediction of lower 
sepsis scores will require more information. These results are mainly due to the 
fact that SI lags condition, resulting in SI values that do not match SSH1 score 
when sepsis state is changing. The result is a loss of diagnostic power largely due 





Identification of an inflammatory response to infection at an early stage would 
enhance the understanding and knowledge of cellular and immunology aspects 
that may cause sepsis, as well as aid decisions to give aggressive care to reduce 
mortality and morbidity. Currently, early detection and treatment is very 
challenging due to the lack of physiological information accessible in real-time 
that is relevant to infection, organ failure and sepsis. This study shows that 
model-based metabolic information on insulin sensitivity, SI, can be highly 
related to SSH1, a specifically modified hourly sepsis scoring system indicating 
sepsis degree. Importantly, it shows that SI decreases with worsening condition 
and increases with improvement in patient condition, which is similar to some 
previous studies [16,17,19,20]. However, information on SI is insufficient to 
determine the exact sepsis condition of a patient particularly at moderate sepsis 
levels (e.g., SSH1 = 1), which are important for early diagnosis as the condition 
develops. Hence, the main contributions of this work are to develop a modified 
clinical sepsis score that can be effectively used hourly for real-time diagnosis 
and monitoring (SSH1) and to show that the impact of sepsis on metabolic 
markers, like SI, is clear, providing an avenue for further study and development 
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